Key Events This Week
17 Aug: Stock opens at ₹800.55, declines 1.06%
18 Aug: Mixed technical signals emerge amid mild momentum shift
19 Aug: Valuation shifts signal elevated price premium; Mojo Grade downgraded to Sell
21 Aug: Week closes at ₹781.85, down 1.03% on the day

Krishna Institute of Medical Sciences Ltd is Rated Sell
2026-08-19 10:10:58Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Krishna Institute of Medical Sciences Ltd Valuation Shifts Signal Elevated Price Premium
2026-08-19 08:01:14Krishna Institute of Medical Sciences Ltd (KIMS) has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, despite delivering robust returns well above the Sensex over multiple time frames. This re-rating reflects a significant premium being placed on the hospital sector stock, raising questions about price attractiveness relative to historical and peer benchmarks.
Read full news article
Krishna Institute of Medical Sciences Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-08-18 08:07:32Krishna Institute of Medical Sciences Ltd (KIMS), a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 17 Aug 2026. Despite a strong year-to-date return of 31.7%, the stock’s recent price action and technical indicators suggest a cautious outlook for investors navigating this evolving landscape.
Read full news article
Krishna Institute of Medical Sciences Ltd: Valuation Shift Signals Price Attractiveness Change
2026-08-13 08:02:02Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and has implications for investors assessing the stock’s price attractiveness relative to its historical and peer benchmarks.
Read full news article









